News

Could opioids be silently undermining cancer immunotherapy? This week, Justin Chickles — CEO and co-founder of Glycyx Therapeutics —...

Many cancer patients are prescribed opioids to manage pain associated with their disease, but studies have shown that the use of these...

This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising...

San Francisco, CA – December 04, 2024 – Glycyx, a clinical-stage biopharmaceutical company advancing axelopran, a novel solution to...